Centric Wealth Management Acquires 338 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Centric Wealth Management raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 6,966 shares of the healthcare conglomerate’s stock after acquiring an additional 338 shares during the period. UnitedHealth Group makes up approximately 1.1% of Centric Wealth Management’s holdings, making the stock its 22nd biggest position. Centric Wealth Management’s holdings in UnitedHealth Group were worth $3,504,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in UNH. International Assets Investment Management LLC raised its position in shares of UnitedHealth Group by 53,573.1% during the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after buying an additional 2,348,107 shares in the last quarter. Jennison Associates LLC lifted its stake in shares of UnitedHealth Group by 49.3% during the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock worth $1,904,670,000 after acquiring an additional 1,195,352 shares during the last quarter. Mawer Investment Management Ltd. lifted its holdings in UnitedHealth Group by 75.0% during the 3rd quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock valued at $1,014,002,000 after buying an additional 862,024 shares in the last quarter. California Public Employees Retirement System increased its holdings in UnitedHealth Group by 35.9% during the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock worth $1,627,311,000 after purchasing an additional 815,822 shares during the period. Finally, Ameriprise Financial Inc. increased its position in UnitedHealth Group by 20.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock valued at $1,879,245,000 after purchasing an additional 623,631 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.4 %

NYSE UNH traded up $1.79 on Wednesday, reaching $502.75. The stock had a trading volume of 1,793,383 shares, compared to its average volume of 4,348,225. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $462.57 billion, a price-to-earnings ratio of 30.62, a P/E/G ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The stock has a fifty day moving average price of $481.45 and a two-hundred day moving average price of $511.98.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. During the same period last year, the business posted $6.26 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.50%. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a research note on Thursday, April 4th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. TD Cowen reduced their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Finally, Barclays upped their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.